haylaavo

J B CHEMICALS AND PHARMA

JBCHEPHARM · NSE · inactive
2,408.90
-97.10 (-3.87%)
as of 16 Jul 2026 close
Open
2,506.00
High
2,525.50
Low
2,380.00
Prev close
2,506.00
52w high
2,525.50
16 Jul 2026
52w low
1,638.50
26 Sept 2025
VWAP
2,418.56
Delivery %
66.8%
of volume
Volume 47.79 L · turnover ₹1155.88 Cr · NSE bhavcopy (official close), adjusted for splits/bonuses · history since 02 Feb 1995
Series
EQ
F&O
No
Status
Inactive since 17 Jul 2026

Source: NSE equity master · as of 16 Jul 2026

Market cap
—
P/B
—
ROE (TTM)
17.1%
ROCE 23.0%
Debt / equity
0.00
P/E (TTM)
—
P/S (TTM)
—
Revenue TTM
₹4,148 cr
Net profit TTM
₹709 cr
Net margin TTM
17.1%
OPM 26.0%
EV / EBITDA
—
Interest cover
172.0×
Revenue growth
-4.8%
latest quarter YoY
Profit growth
-30.4%
latest quarter YoY
Dividend yield
—
₹22 / share · payout —

Consolidated · last four quarters to 2026-03-31 · balance sheet 2026-03-31 · tap a tile for the formula

Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 20:40 IST
  • 05 Feb 21:55
    Management

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr Dilip Singh Rathore as Other of the company w.e.f. March 05, 2026.

    PDF · 304.21 KB
  • 05 Feb 21:55
    Management

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr Kunal Khanna as Other of the company w.e.f. March 05, 2026.

    PDF · 304.21 KB
  • 05 Feb 19:14
    Corporate action

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 11-Feb-2026.

    PDF · 368.40 KB
  • 05 Feb 19:12
    Dividend

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on February 05, 2026, declared Interim Dividend of Rs. 12.70 per equity share.

    PDF · 432.65 KB
  • 05 Feb 18:55
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Change in Key Managerial Personnel - Letter of Resignation

    PDF · 675.00 KB
  • 04 Feb 23:08
    Business update

    JB Chemicals & Pharmaceuticals Limited has informed regarding Disclosure Shifting of Registered Office

    PDF · 555.82 KB
  • 30 Jan 18:30
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 92490 Shares.

    PDF · 326.41 KB
  • 29 Jan 15:42
    Management

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr Narayan Saraf as Chief Financial Officer of the company w.e.f. January 30, 2026.

    PDF · 326.45 KB
  • 21 Jan 21:43
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Transcript

    PDF · 542.50 KB
  • 21 Jan 21:40
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Corrigendum to the Outcome of the first Board Meeting held on 21 January 2026

    PDF · 319.42 KB
  • 21 Jan 15:49
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about General Updates

    PDF · 1.59 MB
  • 21 Jan 14:58
    Board meeting

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on January 21, 2026.

    PDF · 413.82 KB
  • 21 Jan 14:36
    Board meeting

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on January 21, 2026.

    PDF · 1.83 MB
  • 21 Jan 14:13
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 3784100 Shares.

    PDF · 330.96 KB
  • 19 Jan 16:39
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Link of Recording

    PDF · 325.79 KB
  • 17 Jan 17:47
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper advertisement pertaining to financial results for quarter and nine months ended on December 31, 2025

    PDF · 4.51 MB
  • 16 Jan 18:15
    Business update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 16, 2026, titled "Press Release".

    PDF · 688.05 KB
  • 16 Jan 18:15
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation

    PDF · 2.52 MB
  • 16 Jan 18:11
    Board meeting

    JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.

    PDF · 6.98 MB
  • 07 Jan 14:54
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about additional investment in wholly-owned subsidiary

    PDF · 356.48 KB
  • 06 Jan 18:29
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2025

    PDF · 379.96 KB
  • 05 Jan 16:06
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Schedule of meet

    PDF · 436.59 KB
  • 30 Dec 2025 15:18
    Order win

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Receipt of Order

    PDF · 297.55 KB
  • 29 Dec 2025 18:54
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

    PDF · 308.69 KB
  • 24 Dec 2025 17:27
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015- Receipt of Order

    PDF · 320.53 KB
  • 22 Dec 2025 18:58
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about DJSI (Dow Jones Sustainable Index) ESG Score release

    PDF · 286.82 KB
  • 16 Dec 2025 13:42
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015- Receipt of Order

    PDF · 311.82 KB
  • 09 Dec 2025 16:50
    Other

    NovaaOne Capital Pvt Ltd (Manager to the Open Offer) has submitted to the Exchange a copy of Post Offer Advertisement under Regulations 18(12) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended (SEBI (SAST) Regulations) for the attention of the eligible Shareholders of JB Chemicals & Pharmaceuticals Limited (Target Company).

    PDF · 2.47 MB
  • 06 Dec 2025 15:19
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 2500 Shares.

    PDF · 300.22 KB
  • 23 Nov 2025 19:00
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 21056 Shares.

    PDF · 322.70 KB
  • 17 Nov 2025 19:07
    General update

    NovaaOne Capital Private Ltd has submitted to  the Exchange a copy of offer opening advertisement under Regulation 18(7) of SEBI (SAST) Regulations, 2011 as amended (SEBI(SAST) Regulations) and Corrigendum to the detailed public statement for the attention of the eligible shareholders of the company

    PDF · 7.73 MB
  • 14 Nov 2025 18:29
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Transcript

    PDF · 540.07 KB
  • 14 Nov 2025 18:28
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 31161 Shares.

    PDF · 324.27 KB
  • 12 Nov 2025 18:49
    General update

    JB Chemicals & Pharmaceuticals Limited has submitted to  the Exchange a copy of Recommendation of the committee of Independent Director ( IDC) of the company on the open offer(as defined below) made by torrent pharmaceuticals ltd to the eligible shareholders of the company, under Regulation 26(7) of Securities and Exchange Board of India (SAST) Regulations, 2011 and subsequent amendments thereto ( SEBI (SAST) Regulations")

    PDF · 7.44 MB
  • 12 Nov 2025 18:12
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper advertisement pertaining to Recommendations of the Committee of Independent Directors on the Open Offer.

    PDF · 5.52 MB
  • 12 Nov 2025 18:04
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Link of Recording

    PDF · 331.14 KB
  • 12 Nov 2025 13:43
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

    PDF · 2.81 MB
  • 11 Nov 2025 17:11
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation

    PDF · 2.54 MB
  • 11 Nov 2025 17:11
    Business update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 11, 2025, titled "Press Release".

    PDF · 668.13 KB
  • 11 Nov 2025 17:06
    Board meeting

    JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the unaudited financial results for the period ended September 30, 2025.

    PDF · 9.67 MB
  • 07 Nov 2025 11:35
    General update

    NovaaOne Capital Private Limited has Submitted to the Exchange a copy of Letter of Offer.

    PDF · 1.03 MB
  • 31 Oct 2025 17:06
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication regarding shifting of registered office of the Company from Maharashtra to Gujarat.

    PDF · 4.47 MB
  • 31 Oct 2025 14:51
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about update on Investors/analysts call with management

    PDF · 438.56 KB
  • 24 Oct 2025 15:47
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding '4th Sustainability (ESG) Report'.

    PDF · 47.72 MB
  • 24 Oct 2025 15:36
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Schedule of meet

    PDF · 441.67 KB
  • 08 Oct 2025 16:56
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018

    PDF · 389.80 KB
  • 30 Sept 2025 14:14
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

    PDF · 311.08 KB
  • 08 Sept 2025 17:40
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Disclosure under Regulation 30 of the SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015

    PDF · 320.63 KB
  • 04 Sept 2025 19:20
    Compliance

    NovaaOne Capital Private ltd has submitted to  the Exchange a copy of Corrigendum to the public announcement, detailed public statement and the draft letter of offer for the attention of the eligible shareholders of the company.

    PDF · 4.49 MB
  • 01 Sept 2025 18:51
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 140236 Shares.

    PDF · 329.35 KB
Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
  • Results & board-meeting calendar
  • Dividend, split, AGM calendar
  • Headlines with source and timestamp
  • Two-line factual filing summaries